Qualigen Therapeutics, Inc. (QLGN) Ownership

$3.52

south_east
-$0.16 (-4.35%)
Day's range
$3.45
Day's range
$3.67

Qualigen Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 11/14/2022 1.03 M $274.00 K   0.00% 2.60%
BLACKROCK INC. 11/14/2022 258.42 K $69.00 K   0.00% 0.66%
GEODE CAPITAL MANAGEMENT, LLC 11/14/2022 226.67 K $60.00 K   0.00% 0.57%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2022 128.90 K $35.00 K   0.00% 0.33%
STATE STREET CORP 11/15/2022 109.31 K $29.00 K   0.00% 0.28%
HIGHMARK WEALTH MANAGEMENT LLC 10/21/2022 80.09 K $21.00 K   0.00% 0.20%
UBS GROUP AG 11/10/2022 56.78 K $16.00 K   866.25% 0.14%
FRANKLIN RESOURCES INC 11/14/2022 55.45 K $15.00 K   0.00% 0.14%
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. 10/25/2022 48.64 K $13.00 K   0.00% 0.12%
BANK OF AMERICA CORP /DE/ 11/14/2022 47.96 K $13.00 K   36.91% 0.12%
NORTHERN TRUST CORP 11/14/2022 43.25 K $12.00 K   0.00% 0.11%
WEDBUSH SECURITIES INC 10/18/2022 32.23 K $9.00 K   0.00% 0.08%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2022 22.90 K $6.00 K   -62.46% 0.06%
KESTRA ADVISORY SERVICES, LLC 11/01/2022 20.00 K $5.00 K   0.00% 0.05%
CRA FINANCIAL SERVICES, LLC 10/24/2022 19.96 K $5.00 K   0.00% 0.05%
BANK OF NEW YORK MELLON CORP 11/14/2022 18.88 K $5.00 K   0.00% 0.05%
GROUP ONE TRADING, L.P. 11/09/2022 18.25 K $5.00 K   0.00% 0.05%
RENAISSANCE TECHNOLOGIES LLC 11/14/2022 14.50 K $4.00 K   100.00% 0.04%
TOWER RESEARCH CAPITAL LLC (TRC) 11/10/2022 13.25 K $4.00 K   43.66% 0.03%
CITADEL ADVISORS LLC 11/14/2022 12.10 K $3.00 K   -71.93% 0.03%
US BANCORP \DE\ 10/27/2022 8.24 K $2.00 K   0.00% 0.02%
RETIREMENT GROUP, LLC 11/14/2022 3.50 K $1.00 K   100.00% 0.01%
SIMPLEX TRADING, LLC 11/04/2022 536 $0   100.00% 0.00%
WELLS FARGO & COMPANY/MN 11/14/2022 258 $0   18.89% 0.00%
GLASSMAN WEALTH SERVICES 11/09/2022 200 $0   0.00% 0.00%
GUARDIAN WEALTH ADVISORS, LLC 11/09/2022 200 $0   100.00% 0.00%
ARCHER INVESTMENT CORP 11/09/2022 160 $43   0.00% 0.00%
ROYAL BANK OF CANADA 11/14/2022 48 $0   0.00% 0.00%
MORGAN STANLEY 11/14/2022 11 $0   1,000.00% 0.00%
IFP ADVISORS, INC 11/08/2022 1 $1.00 K   0.00% 0.00%
CREDIT SUISSE AG/ 11/10/2022 1 $0   0.00% 0.00%
ATLAS CAPITAL ADVISORS LLC 11/08/2022 1 $0   100.00% 0.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 11/15/2022 0 $0   0.00% 0.00%
CREATIVE PLANNING 11/03/2022 0 $0   -100.00% 0.00%
SOLTIS INVESTMENT ADVISORS LLC 11/14/2022 0 $0   -100.00% 0.00%
TD WATERHOUSE CANADA INC. 11/13/2023 0 $0   -100.00% 0.00%

Qualigen Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 2 institutional investors and hedge funds held shares of Qualigen Therapeutics, Inc.. The most heavily invested institutionals were:

HATTON CONSULTING, INC.: 27,195

QS Investors, LLC: 82,000

5.66% of Qualigen Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 109.20 K shares in the last 24 months. This purchase volume represents approximately $384.37 K in transactions.